Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Nova IVI Fertility Launches New Center in Jalandhar


News provided by

Nova Medical Centers Pvt Ltd

13 Mar, 2014, 13:09 IST

Share this article

Share toX

Share this article

Share toX

PR Newswire India - Nova IVI Fertility Logo (PRNewsFoto/Nova IVI Fertility)
PR Newswire India - Nova IVI Fertility Logo (PRNewsFoto/Nova IVI Fertility)

JALANDHAR, India, March 13, 2014 /PRNewswire/ --

India's Largest Chain of Fertility Centers Sets up its Newest Facility in Punjab to Offer Couples the Best Treatment Using the Latest Technology

Infertility is on the rise in India due to numerous reasons including genetic disorders, stress, urbanization, late settlement in life as well as the rising incidence of an unhealthy lifestyle. A recent study estimates approximately 15%-20% of married couples in their fertile age group suffer from infertility. It is an increasingly prevalent health concern and treatments are widely being sought to overcome infertility related disorders. However, there is a widespread shortage of standardized clinical protocols, structured training, quality laboratories, qualified embryologists and ethical practices.

     (Logo: http://photos.prnewswire.com/prnh/20140313/10090947)

Filling in this gap and bringing to fore a trusted and a credible partner offering standardised and ethical infertility treatment to couples with the latest techniques, Nova IVI Fertility launched its 7th center in India in the city of Jalandhar today. Part of Nova Medical Centers, the Nova IVI Fertility center in Jalandhar was inaugurated by Manpreet Singh Chattwal, Commissioner, Municipal Corporation, in the presence of Suresh Soni, Chairman and CEO, Nova Medical Centers, V.P. Kamath, Group COO, Nova Medical Centers and Dr. Jasmine Kaur, Clinical Director, Nova IVI Fertility - Jalandhar.

Speaking at the launch, Suresh Soni, Chairman and CEO, Nova Medical Centers, said, "We are extremely happy to announce the opening of our center in Jalandhar, which will also act as a focal point catering to nearby areas in the state of Punjab. This center brings together renowned specialists with state-of-the-art technology and extensive services all under one roof. The new facility in Jalandhar is a step ahead in realising Nova's commitment towards offering standardised and ethical infertility treatment, as well as addressing the urgent need for an organized institutional provider for fertility treatment. With six well-established fertility centers in major cities and the seventh one in Jalandhar, Nova IVI Fertility plans to launch as many as 10 centers in a year's time with the goal of bringing high quality assisted reproductive therapy to the people of India."

In addition to providing core procedures such as IUI, IVF, and Andrology services, Nova IVI Fertility - Jalandhar will offer several state-of-the-art technologies such as assisted hatching, blastocyst culture, and vitrification. This center will also offer another sought after advanced technique known as IMSI (intracytoplasmic morphologically-selected sperm injection). This is an upgrade of ICSI (intracytoplasmic sperm injection), where the embryologist carries out the fertilization of the oocytes (egg) using an extremely high-powered microscope to select the sperm cells with the best morphological quality.

Dr. Jasmine Kaur, Clinical Director, Nova IVI Fertility, Jalandhar, added, "In my career, I have come across hundreds of couples wanting to have children but who have been unlucky. With my experience, I have learnt that with a little patience, compassion and the right technology, we can bring joy into the lives of our patients. Nova IVI Fertility center at Jalandhar is fully equipped with the latest technology available in the world and offers the most effective treatment to patients, while following international guidelines to ensure positive results."

Nova IVI stems from a partnership between Nova Medical Centers and IVI, Spain, to introduce the most sophisticated advanced Assisted Reproductive Technology in India. This partnership has resulted in substantial addition to Nova's IVF services and technology, including proprietary software, training and quality management. With IVI's know-how and vast international expertise, Nova brings the same exceptional standard of processes, protocols and policies that has helped thousands of births. More importantly, the Nova IVI ART Bank now provides oocyte freezing (vitrification) and Pre-implantation Genetic Diagnosis (PGD) in India. This successful partnership has helped establish a world-class research facility in India that has the most robust database for clinical research in the field of infertility treatments, making Nova IVI a market leader in ART and clinical outcomes.

Nova IVI Fertility is already present in Ahmedabad, Bengaluru, Kolkata, Mumbai, New Delhi and Chennai.

About Nova Medical Centers

Nova Medical Centers is the parent company of Nova Specialty Hospitals and Nova IVI Fertility. It currently operates 11 specialty surgery centers and 7 fertility centers. Nova was co-founded by Suresh Soni, renowned shoulder surgeon Dr. Mahesh Reddy and the GTI Group, based on a "doctor-owned and doctor-managed" concept enabling doctors to have a sense of ownership and a long-term association with the company. This concept also allows doctors to deliver the best possible patient care in an open and free environment.

Established in 2009, Nova Specialty Hospitals' mission is to provide world-class surgical care that is accessible and at an affordable cost. Having pioneered the concept of short-stay surgical care in India, Nova focuses on providing the finest quality care for patients from specialized doctors while increasing operating efficiency.

Nova IVI Fertility is a joint venture between Nova Pulse, India, and IVI, Spain, introducing the same exceptional standard of processes, protocols and policies to deliver the most sophisticated Assisted Reproductive Technology (ART) in India.

Nova's vision is to create a novel institution that stands for excellence in healthcare services by providing the best patient experience and is an international reference for clinical outcomes, by adopting the latest advances in medical sciences, technology and an innovative business model.

For further information, please visit http://www.novamedicalcenters.com, http://www.novaivifertility.com

Facebook: https://www.facebook.com/NovaIVIFertility
Twitter: https://twitter.com/NovaIVIFertilit
Pinterest: http://www.pinterest.com/novaivi/
Google Plus: https://plus.google.com/+Novaivifertility/posts 

Primary Media Contact: Parul Vaid, [email protected], 91-9873212501

Secondary Media Contact: Megha Kapoor, [email protected], 91-9811656488

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.